Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yuka Shimizu, Shinsuke Yasuda, Taichi Kimura, Saori Nishio, Michihiro Kono, Kazumasa Ohmura, Sanae Shimamura, Michihito Kono, Yuichiro Fujieda, Masaru Kato, Kenji Oku, Toshiyuki Bohgaki, Yuichiro Fukasawa, Shinya Tanaka & Tatsuya Atsumi. (2018) Interferon-inducible Mx1 protein is highly expressed in renal tissues from treatment-naïve lupus nephritis, but not in those under immunosuppressive treatment. Modern Rheumatology 28:4, pages 661-669.
Read now
Read now
Articles from other publishers (7)
Ching-Mao Chang, Po-Chang Wu, Jen-Huai Chiang, Yau-Huei Wei, Fang-Pey Chen, Tzeng-Ji Chen, Tai-Long Pan, Hung-Rong Yen & Hen-Hong Chang. (2017) Integrative therapy decreases the risk of lupus nephritis in patients with systemic lupus erythematosus: A population-based retrospective cohort study. Journal of Ethnopharmacology 196, pages 201-212.
Crossref
Crossref
Marisa Klein-Gitelman & Jerome Charles Lane. 2016. Textbook of Pediatric Rheumatology. Textbook of Pediatric Rheumatology
285
317.e14
.
Jinfeng Yang, Zhaozhen Xu, Manshu Sui, Jihua Han, Lijie Sun, Xiuzhi Jia, Haiyu Zhang, Changsong Han, Xiaoming Jin, Fei Gao, Yanhong Liu, Yang Li, Jianbin Cao, Hong Ling, Fengmin Zhang & Huan Ren. (2015) Co-Positivity for Anti-dsDNA, -Nucleosome and -Histone Antibodies in Lupus Nephritis Is Indicative of High Serum Levels and Severe Nephropathy. PLOS ONE 10:10, pages e0140441.
Crossref
Crossref
Hong-Na Wang, Xiao-Ye Zhu, Ying Zhu, Qiong-Hong Xie, Lin-Yun Lai, Miao Zhao, Yuan-Cheng Chen, Jun Xue, Chuan-Ming Hao, Yong Gu & Shan-Yan Lin. (2015) The GSTA1 polymorphism and cyclophosphamide therapy outcomes in lupus nephritis patients. Clinical Immunology 160:2, pages 342-348.
Crossref
Crossref
Lucía Ramos & David Isenberg. (2015) Rituximab: the Lupus Journey. Current Treatment Options in Rheumatology 1:1, pages 30-41.
Crossref
Crossref
Jennifer H. Austin, Leah E. Bentley, Denise M. Kolanczyk & Nishil P. Patel. (2013) Refractory Proliferative Lupus Nephritis. Journal of Pharmacy Technology 29:6, pages 265-282.
Crossref
Crossref
Hua Zhou, Sarfaraz A. Hasni, Paola Perez, Mayank Tandon, Shyh-Ing Jang, Changyu Zheng, Jeffery B. Kopp, Howard Austin, James E. Balow, Ilias Alevizos & Gabor G. Illei. (2013) miR-150 Promotes Renal Fibrosis in Lupus Nephritis by Downregulating SOCS1. Journal of the American Society of Nephrology 24:7, pages 1073-1087.
Crossref
Crossref